About the same time that Leary was working on his vaccine, Rosenau prepared an unheated suspension of Pfeiffer bacilli, isolated from cases of influenza of the existing epidemic, which he used at the Chelsea Naval Hospital and in an experiment at the Pelham Bay Naval Training Station. The writer is indebted to Surgeon-General of the Navy W. C. Braisted for the data from which this report was compiled—the report of the Sanitary Officer of the station not having been completed at the time the information was furnished. The vaccine experiment was made in the isolation regiment, which had remained practically free of influenza. Inoculations were begun on September 30, when 638 men were given the first dose of vaccine, 833 men being held as controls. On October 4 the second dose was given to 589 men, and vaccination was completed on October 8, when 565 men were inoculated. This group comprised the total number who received three inoculations. On October 14 practically all of these men were transferred, so that it was very difficult to get a complete record. Those cases which developed influenza prior to October 10 have been omitted by the writer, both from the control and vaccinated groups, because it is unfair to consider the incidence of influenza among controls which developed prior to the time the inoculations were completed in the vaccinated group. Between October 10 and October 24 there were 27 cases of influenza which developed among the vaccinated, and 30 among the controls, giving a morbidity rate of 3.6 per cent. among the 833 controls, as compared to 4.7 per cent. among the 565 vaccinated men. Emphasis is laid on the fact that these morbidity rates were calculated for both groups on the number of cases that appeared after vaccination had been completed. The result failed to show protective qualities in the vaccine.